The American company gets permission to launch embryo's old macula lutea sex change test of stem cell's treatment

The American company gets permission to launch embryo's old macula lutea sex change test of stem cell's treatment
Washington 1 of Xinhua News Agency Cable of the 3rd of moon (reporter Ren HaiJun) American Advanced Cell Technology Inc announces on the 3rd, clinical trial that American Food and Drug Administration has already approved this company for utilizing embryo's old macula lutea of stem cell's treatment to change the sex.
CEOs of company Gary and Rabin say in a statement on the same day, this company has already been in charge of the company that the office sanctions launching embryo's stem cell's clinical trial the medicine as first two at present. Get permission, launch, it tests to be not only stem cell research field but also may modern the intersection of health care and an important step that field takes forward while being above-mentioned.
Declare, the clinical trial will be launched within several months, the company will strive to get permission to study in Europe similarly.
Massachusetts state of U.S.A. -based Advanced Cell Technology Inc had got permission to utilize embryo's stem cell's treatment to treat the clinical trial of the disease of special dose of Sri Lankan last November. Before this, American medicine is in charge of office's already approving the outstanding dragon's biological pharmaceuticals for utilizing embryo's stem cell to treat the clinical trial that the spinal damages the patient, this is a human embryo's clinical trial of stem cell's treatment that U.S.A. sanctions being implemented.
It is one of the common irreversible blind reasons in the crowd over 60 that the old macula lutea changes the sex, there is no effective treatment yet at present. It is reported at present, U.S.A. and Europe have 3000 people Wan suffer from, might cause macula lutea that macula lutea change the sex degradate nearly. Advanced Cell Technology Inc estimates, this disease contains the market of total value between 250 hundred million to 300 hundred million dollars.
Embryo's stem cell can divide into any type of body cells, there is extensive application prospect in medical science. However, because embryo's stem cell should draw from the embryo, involve ethics and ethical question, study relevantly and cause much controversies in U.S.A. .
|